Featured Research

from universities, journals, and other organizations

Freezing Kidney Tumors Effective And Less Expensive Than Laparoscopy

Date:
March 21, 2007
Source:
Society of Interventional Radiology
Summary:
The nonsurgical treatment of kidney tumors -- cryoablation -- is as effective as the surgical laparoscopic technique in viable candidates. The comparative trial shows that cryoablation results in a slightly lower recurrence rate of the tumor, a shorter hospital stay, no major complications, and a 59.5 percent lower hospital cost than the laparoscopic treatment.

The nonsurgical treatment of kidney tumors – cryoablation – is as effective as the surgical laparoscopic technique in viable candidates. The comparative trial shows that cryoablation results in a slightly lower recurrence rate of the tumor, a shorter hospital stay, no major complications, and a 59.5 percent lower hospital cost than the laparoscopic treatment.

During cryoablation argon gas enters the tip of the probe and extracts heat from the surrounding cells, resulting in an “ice ball” that freezes and kills the tumor. The nonsurgical treatment spares the majority of the healthy kidney tissue and can be repeated as often as needed. This interventional treatment had no major complications as opposed to the surgical group, which experienced complications in six percent of those studied.

The radiologist uses imaging to pinpoint the tumor, and then inserts the cryoprobe through the skin, similar to the way a biopsy is performed. This can be performed under general anesthesia, but is often possible with only local anesthesia and conscious sedation. By using imaging the radiologist can avoid going through any adjacent structures or harming healthy tissue. If necessary, adjacent structures can be displaced prior to the ablation to minimize collateral damage. Laparoscopy, on the other hand, requires general anesthesia, as well as multiple abdominal incisions to allow access for the surgical instruments. It is also associated with a longer recovery time.

“This early stage research indicates that percutaneous cryoablation in the appropriate patient population can effectively kill tumors, while also offering patients a shorter hospital stay, a faster recovery, and an excellent safety profile, all at a lower cost than laparoscopy,” noted study author J. Louis Hinshaw, M.D., of the University of Wisconsin. “Unfortunately, not all patients are viable candidates for percutaneous ablation and we work closely with our urology colleagues to ensure that each patient receives the most appropriate treatment.”

The FDA has approved both radiofrequency ablation and cryoablation for use in soft tissue tumors, of which renal cell carcinoma is one.

“We are excited about this study because it offers patients with renal cell carcinoma a less traumatic treatment that can be repeated as needed,” Hinshaw added. “Depending on the stage of the disease, this procedure can be curative, but can also be used for palliative treatment in some settings.”

In the study, 19 percutanous and 48 laparoscopic cryoablations were performed and compared. The results indicated:

  • Laparoscopic cryoablation had a slightly higher tumor recurrence rate (12.5 vs. 10.5 percent)
  • Percutaneous cryoablation required fewer days in the hospital (1.1 vs. 2.5)
  • Percutaneous cryoablation had no major complications (0 vs. 6.3 percent)
  • Percutaneous cryoablation cost 59.5 percent less than laparoscopic approach

About Kidney Cancer

Kidney cancer is the eighth most common cancer in men and the tenth in women. The most common type of kidney cancer is renal cell carcinoma that forms in the lining of the renal tubules in the kidney that filter the blood and produce urine. Approximately eighty-five percent of kidney tumors are renal cell carcinomas.

Surgical removal of tumors confined to the kidney offers the best chance for a cure. Unfortunately, some patients may not tolerate surgery due to underlying medical conditions, and some patients, particularly those with small tumors, may not want to have surgery for their cancer. In this group of patients, minimally invasive image-guided therapies offer a less invasive option. These interventional treatments can also offer valuable benefits to some patients with advanced or metastatic renal cell carcinoma. Chemotherapy drugs and radiation are generally ineffective at curing kidney cancer.

More than 32,000 Americans each year are diagnosed with kidney cancer—many of them don’t have symptoms. Typically, those with kidney cancer are past the age of 40 and are twice as likely to be men. Other risk factors include smoking, obesity, high blood pressure, long-term dialysis and Von Hippel-Lindau syndrome.


Story Source:

The above story is based on materials provided by Society of Interventional Radiology. Note: Materials may be edited for content and length.


Cite This Page:

Society of Interventional Radiology. "Freezing Kidney Tumors Effective And Less Expensive Than Laparoscopy." ScienceDaily. ScienceDaily, 21 March 2007. <www.sciencedaily.com/releases/2007/03/070320103508.htm>.
Society of Interventional Radiology. (2007, March 21). Freezing Kidney Tumors Effective And Less Expensive Than Laparoscopy. ScienceDaily. Retrieved August 30, 2014 from www.sciencedaily.com/releases/2007/03/070320103508.htm
Society of Interventional Radiology. "Freezing Kidney Tumors Effective And Less Expensive Than Laparoscopy." ScienceDaily. www.sciencedaily.com/releases/2007/03/070320103508.htm (accessed August 30, 2014).

Share This




More Health & Medicine News

Saturday, August 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins